News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
Pharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumEducated PatientInformation for the PharmacistInteractive ToolsPartnersSponsoredWhiteboards

Subscribe

  • News
    • All News
    • FDA Updates
    • Press Releases
  • Media
    • Conferences
      • Publications
        • Events
          • CE
          • Resources
            • Subscribe
            • 503B Compounding Pharmacy
            • ADHD
            • Allergy
            • Alzheimer Disease
            • Anxiety
            • Asthma
            • Atopic Dermatitis
            • Biosimilars
            • Bipolar Disorder
            • Brain Health
            • Breast Cancer
            • C. difficile
            • COPD
            • COVID-19
            • Cardiovascular Health
            • Cervical Cancer
            • Cholangiocarcinoma
            • Cholesterol
            • Chronic Kidney Disease
            • Chronic Lymphocytic Leukemia
            • Classical Hematology
            • Colorectal Cancer
            • Continuous Glucose Monitoring
            • Cough and Cold
            • Depression
            • Dermatology
            • Diabetes
            • Digestive Health
            • Dry Eye Disease
            • Epilepsy
            • Eye Care
            • Flu
            • Future of Pharmacy
            • Gastrointestinal Cancer
            • Gastrointestinal Health
            • Gout
            • HER2 Breast Cancer
            • HIV
            • Heart Failure
            • Hematology
            • Hepatitis/MASH
            • Immunization
            • Immuno-oncology
            • Immunoglobulins
            • Infectious Disease
            • Lung Cancer
            • Lymphoma
            • Macular Degeneration
            • Mental Health
            • Migraine
            • Movement Disorders
            • Multiple Myeloma
            • Multiple Sclerosis
            • Myelofibrosis
            • Neurology
            • Neutropenia
            • Osteoporosis
            • Ovarian Cancer
            • Pain Management
            • Parkinson Disease
            • Pediatrics
            • Pneumococcal
            • PrEP
            • Prostate Cancer
            • Psoriasis
            • Psoriatic Arthritis
            • Psychedelics
            • Reproductive Health
            • Respiratory Syncytial Virus
            • Rheumatoid Arthritis
            • Schizophrenia
            • Shingles
            • Skin Cancer
            • Sleep
            • Travel Vaccines
            • Veterinary Pharmacy
            • Vitamins and Supplements
            • Weight Management
            • Women's Health
            Spotlight -
            Community/Retail|
            Hospital|
            Oncology|
            Pharmacy Technician|
            Student
            Advertisement

            Melissa Martinez, PharmD

            Advertisement

            Articles by Melissa Martinez, PharmD

            From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL

            ByAmi Ali, PharmD, BCOP,Melissa Martinez, PharmD ,Martina Nasralla, PharmD Candidate,Zyanya Rizzo, PharmD Candidate,Lamya Al-Saleh, PharmD, RPh
            August 13th 2025

            BV-R2 combination shows survival benefit across high-risk subgroups.

            Acute lymphoblastic leukemia (ALL) cancer cells in the blood flow -- Image credit: LASZLO | stock.adobe.com

            Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population

            ByAmir Ali, PharmD, BCOP,Melissa Martinez, PharmD ,Maryam Saheb Kashaf, PharmD Candidate,Zyanya Rizzo, PharmD Candidate
            January 17th 2024

            Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.

            Image Credit: Fabrizio - stock.adobe.com

            Novel Drug Combinations in Precision Medicine Are an Emerging Landscape for Pharmacists

            ByAmir Ali, PharmD, BCOP,Merry Ann Sta Maria, PharmD Candidate,Melissa Martinez, PharmD ,Jose Tinajero, PharmD, BCOP
            October 10th 2023

            A single-center experience at a tertiary medical center precision medicine clinic provides insight.

            Advertisement

            Latest Updated Articles



              Advertisement
              Advertisement

              Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

              1

              Improved Outcomes in NDTE Multiple Myeloma With Belantamab Mafodotin Plus VRd Following 2 Years of Maintenance

              2

              Inclisiran, PCSK9s Elicits Sustained LDL-C Reductions in Familial Hypercholestrolemia

              • About Us
              • Clinical Forums
              • Advertise
              • Contact Us
              • Editorial Staff
              • Privacy Policy
              • Terms & Conditions
              • Do Not Sell My Information
              Contact Info

              259 Prospect Plains Rd, Bldg H
              Monroe, NJ 08831

              609-716-7777

              • Contemporary Clinic
              • OTC Guide
              • Pharmacy Times
              • Pharmacist Mom's Group
              • Pharmacist Mom's Group
              Pharmacy Times
              Brand Logo

              © 2025 MJH Life Sciences®

              All rights reserved.

              Home
              About Us
              News
              Contact Us